Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Thery Biological Product is a China-based biotechnology company specializing in the development of next-generation exosome-based therapeutics. The company leverages a proprietary platform for the isolation, engineering, and large-scale production of exosomes to deliver therapeutic payloads or exert direct biological effects. Their research focus primarily spans oncology and inflammatory conditions, aiming to utilize the natural communication properties of exosomes for targeted drug delivery. Thery Biological has established integrated capabilities ranging from upstream R&D to GMP-compliant manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Thery Biological Product.